Market News AIOpen the app

QNRX stock news · Quoin Pharmaceuticals Ltd.

Stories about Quoin Pharmaceuticals Ltd. (QNRX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for QNRX

Follow Quoin Pharmaceuticals Ltd. (QNRX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for QNRX
Free on the App Store and Google Play, or on the web.
  1. Oct 20, 2026, 6:42 AM ET · Market

    Quoin Pharmaceuticals shares news about a study showing good results for its treatment QRX003 in kids.

    Good for QNRX

    Quoin Pharmaceuticals reported lasting skin and itch improvements in a child using QRX003, plus positive early trial results. This supports the drug’s promise, but more testing is needed.

  2. Oct 14, 2026, 6:37 AM ET · Market

    Quoin Pharmaceuticals says its main drug QRX003 got special status from Europe for treating Peeling S.

    Good for QNRX

    Quoin received special European status for QRX003, its treatment candidate for Peeling Skin Syndrome. The support is encouraging, but approval and a formal study still lie ahead.

  3. Oct 7, 2026, 5:12 PM ET · Market

    12 health care companies saw big changes in their stock prices after the market closed on Wednesday.

    Neutral

    Quoin Pharmaceuticals shares rose 10.86% to $5.00 after hours, but the roundup gives no company news, so its business outlook is unchanged.